Abstract
ObjectivesTo analyse the perspective of clinical research stakeholders concerning post-trial access to study medication.MethodsQuestionnaires and informed consents were sent through e-mail to 599 ethics committee (EC) members, 290 clinical investigators...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
